Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]
Abstract
Share and Cite
HAMDEN, K.; MNAFGUI, K.; AMRI, Z.; ALOULOU, A.; ELFEKI, A. Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]. Sci. Pharm. 2014, 82, 449-452. https://doi.org/10.3797/scipharm.1211-14corr
HAMDEN K, MNAFGUI K, AMRI Z, ALOULOU A, ELFEKI A. Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]. Scientia Pharmaceutica. 2014; 82(2):449-452. https://doi.org/10.3797/scipharm.1211-14corr
Chicago/Turabian StyleHAMDEN, Khaled, Kais MNAFGUI, Zahra AMRI, Ahmed ALOULOU, and Abdelfattah ELFEKI. 2014. "Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]" Scientia Pharmaceutica 82, no. 2: 449-452. https://doi.org/10.3797/scipharm.1211-14corr
APA StyleHAMDEN, K., MNAFGUI, K., AMRI, Z., ALOULOU, A., & ELFEKI, A. (2014). Corrigendum to "Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats" [Sci Pharm. 2013; 81: 233–246]. Scientia Pharmaceutica, 82(2), 449-452. https://doi.org/10.3797/scipharm.1211-14corr